Xeltis

Description: Xeltis develops bioabsorbable heart valves & vessels enabling natural cardiovascular restoration through Endogenous Tissue Restoration (ETR).

Country: Switzerland

Based in: Zurich

Founded: 2008

Funding Stage: Series C & Beyond

Tags: ['medtech', 'health', 'medical services', 'devices', 'heart']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.